TruBridge, Inc. (TBRG)
NASDAQ: TBRG · Real-Time Price · USD
26.27
+1.46 (5.88%)
At close: May 12, 2025, 4:00 PM
26.27
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
TruBridge Market Cap
TruBridge has a market cap or net worth of $381.50 million as of May 12, 2025. Its market cap has increased by 232.03% in one year.
Market Cap
381.50M
Enterprise Value
542.20M
1-Year Change
232.03%
Ranking
Category
Stock Price
$26.27
Market Cap Chart
Since May 21, 2002, TruBridge's market cap has increased from $190.00M to $381.50M, an increase of 100.79%. That is a compound annual growth rate of 3.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 372.70M | 26.64% |
Dec 31, 2024 | 294.30M | 80.66% |
Dec 29, 2023 | 162.90M | -58.77% |
Dec 30, 2022 | 395.10M | -7.95% |
Dec 31, 2021 | 429.20M | 10.19% |
Dec 31, 2020 | 389.50M | 2.77% |
Dec 31, 2019 | 379.00M | 7.18% |
Dec 31, 2018 | 353.60M | -14.47% |
Dec 29, 2017 | 413.40M | 29.43% |
Dec 30, 2016 | 319.40M | -43.20% |
Dec 31, 2015 | 562.30M | -17.42% |
Dec 31, 2014 | 680.90M | -1.28% |
Dec 31, 2013 | 689.70M | 23.67% |
Dec 31, 2012 | 557.70M | -1.36% |
Dec 30, 2011 | 565.40M | 10.11% |
Dec 31, 2010 | 513.50M | 1.62% |
Dec 31, 2009 | 505.30M | 73.23% |
Dec 31, 2008 | 291.70M | 18.63% |
Dec 31, 2007 | 245.90M | -32.74% |
Dec 29, 2006 | 365.60M | -16.81% |
Dec 30, 2005 | 439.50M | 81.01% |
Dec 31, 2004 | 242.80M | 15.07% |
Dec 31, 2003 | 211.00M | -18.75% |
Dec 31, 2002 | 259.70M | 36.68% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |